Cargando…

Coated Flow Diverters and Single Antiplatelet Treatment: Where are We?

Detalles Bibliográficos
Autor principal:	Pierot, Laurent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458681/ https://www.ncbi.nlm.nih.gov/pubmed/35817931 http://dx.doi.org/10.1007/s00270-022-03185-0

Ejemplares similares

Coating (Coating to Optimize Aneurysm Treatment in the New Flow Diverter Generation) study. The first randomized controlled trial evaluating a coated flow diverter (p64 MW HPC): study design
por: Pierot, Laurent, et al.
Publicado: (2023)

The p48_HPC antithrombogenic flow diverter: initial human experience using single antiplatelet therapy
por: Bhogal, Pervinder, et al.
Publicado: (2019)

AI in medicine: Where are we now and where are we going?
por: Shandhi, Md Mobashir Hasan, et al.
Publicado: (2022)

Breast cancer research: where we are and where we should go
por: Liu, Edison T
Publicado: (2000)

Commentary: we can tell where it hurts, but can we tell where the pain is coming from or where we should manipulate?
por: Brady, O’Dane, et al.
Publicado: (2013)

Commentary: Retinoblastoma management—Where are we and where do we go from here?
por: Shanmugam, P Mahesh
Publicado: (2020)

Neoadjuvant treatment of rectal cancer: where are we now?
por: Kalyan, Aparna, et al.
Publicado: (2016)

Implementation of Outpatient Total Joint Arthroplasty in Canada: Where We are and Where We Need to Go
por: Zomar, Bryn O, et al.
Publicado: (2020)

Commentary: COVID-19 and ocular inflammation: Where do we stand and where are we headed?
por: Sheth, Jay U
Publicado: (2021)

Vascular Response on a Novel Fibrin-Based Coated Flow Diverter
por: Mühl-Benninghaus, Ruben, et al.
Publicado: (2021)

Comparison of the Thrombogenicity of a Bare and Antithrombogenic Coated Flow Diverter in an In Vitro Flow Model
por: Lenz-Habijan, T., et al.
Publicado: (2019)

Where we are with point-of-care testing
por: Johannessen, A
Publicado: (2015)

Electronic cigarettes – where are we headed?
por: Loughead, Andrew
Publicado: (2015)

Plasmodium vivax malaria vaccines: Why are we where we are?
por: Reyes-Sandoval, Arturo, et al.
Publicado: (2013)

Use of a p64 MW Flow Diverter with Hydrophilic Polymer Coating (HPC) and Prasugrel Single Antiplatelet Therapy for the Treatment of Unruptured Anterior Circulation Aneurysms: Safety Data and Short-term Occlusion Rates
por: Hellstern, V., et al.
Publicado: (2022)

Dermatology education in skin of colour: where we are and where do we go?
por: Onasanya, Joshua, et al.
Publicado: (2021)

Treatment of Diabetes in Bullous Pemphigoid Patients: Where Do We Stand?
por: Alexandre, Maria Inês, et al.
Publicado: (2023)

Preliminary outcomes of single antiplatelet therapy for surface-modified flow diverters in an animal model: analysis of neointimal development and thrombus formation using OCT
por: Matsuda, Yoshikazu, et al.
Publicado: (2019)

Hyperglycemia diverts dividing stem cells to pathological adipogenesis
por: Hascall, Vincent, et al.
Publicado: (2014)

Acute childhood leukemia in India: Where are we going, where have we been?
por: Kanwar, Vikramjit Singh
Publicado: (2016)

Artificial intelligence in colonoscopy: where have we been and where should we go?
por: Mohan, Babu P., et al.
Publicado: (2023)

Ventilator-associated tracheobronchitis: where are we now?
por: Nseir, Saad, et al.
Publicado: (2014)

Predicting Molecular Models: Where Are We Going?
por: Ratta, Raffaele, et al.
Publicado: (2015)

Genetics and primary care: where are we headed?
por: Rahimzadeh, Vasiliki, et al.
Publicado: (2014)

Genetic counseling globally: Where are we now?
por: Ormond, Kelly E., et al.
Publicado: (2018)

Flow Diverters for Intracranial Aneurysms
por: Alderazi, Yazan J., et al.
Publicado: (2014)

Peripherin diverts ciliary ectosome release to photoreceptor disc morphogenesis
por: Molday, Robert S., et al.
Publicado: (2017)

Gene therapy for arthritis – where do we stand?
por: Chernajovsky, Yuti
Publicado: (2005)

COVID-19 – Where should we go now?
por: Allen, Claire, et al.
Publicado: (2020)

Commentary: Retinopathy of prematurity: Where do we stand?
por: Parchand, Swapnil M, et al.
Publicado: (2021)

The WHO pandemic treaty: where are we on our scepticism?
por: Evaborhene, Nelson Aghogho, et al.
Publicado: (2023)

World Health Organization AWaRe framework for antibiotic stewardship: Where are we now and where do we need to go? An expert viewpoint
por: Mudenda, Steward, et al.
Publicado: (2023)

Commentary: Thoracoscopic-Assisted Rib Plating: Where We Are and What We Have Learned
por: Kim, Seon Hee, et al.
Publicado: (2023)

Tubridge flow diverter for the treatment of small and medium aneurysms
por: Xie, Dajiang, et al.
Publicado: (2023)

Early Treatment of Ruptured Blood Blister-Like Aneurysms of the Internal Carotid Artery With Flow Diverters Using Single Antiplatelet Therapy: A Single-Center Experience With Long-Term Follow-Up
por: Tanburoglu, Anil, et al.
Publicado: (2021)

Dental genetics in Brazil: Where we are
por: Casado, Priscila L., et al.
Publicado: (2018)

Women in neuroscience: Where are we in 2019?
por: Machlovi, Saima, et al.
Publicado: (2020)

Anti-cytokine therapy in fibrosing alveolitis: where are we now?
por: Millar, Ann
Publicado: (2000)

Hemofiltration in sepsis: where do we go from here?
por: Kellum , John A, et al.
Publicado: (2000)

Perioperative care in perforation peritonitis: Where do we stand?
por: Garg, Rakesh
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_enh1somsq7cpdra3tu3kf0d14f